Are you Dr. Gould?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 67 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
550 Peachtree St Ne
7th Floor
Atlanta, GA 30308Phone+1 404-686-8114Fax+1 404-686-4841
Summary
- Dr. Carolyn Gould, MD is an infectious disease specialist in Atlanta, Georgia. She is currently licensed to practice medicine in Georgia and Pennsylvania. She is affiliated with Emory University Hospital Midtown, Grady Health System, and Emory University Hospital.
Education & Training
- University of Pennsylvania Health SystemFellowship, Infectious Disease, 2001 - 2003
- University of Pennsylvania Health SystemResidency, Internal Medicine, 1998 - 2001
- Perelman School of Medicine at the University of PennsylvaniaClass of 1998
Certifications & Licensure
- GA State Medical License 2003 - 2025
- PA State Medical License 1999 - 2004
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 82 citationsDiagnosis, management, and prevention of catheter-associated urinary tract infections.Carol E. Chenoweth, Carolyn V. Gould, Sanjay Saint
Infectious Disease Clinics of North America. 2014-03-01 - 309 citationsCurrent Status of Clostridium difficile Infection EpidemiologyFernanda C. Lessa, Carolyn V. Gould, L. Clifford McDonald
Clinical Infectious Diseases. 2012-08-01 - 79 citationsEffect of Nucleic Acid Amplification Testing on Population-Based Incidence Rates of Clostridium difficile InfectionCarolyn V. Gould, Jonathan R. Edwards, Jessica Cohen, Wendy Bamberg, Leigh Ann Clark
Clinical Infectious Diseases. 2013-11-01
Press Mentions
- Exceptional Nurse Manager Lulu Pearl Kwakye, MSN, MHA, BBA, RN, Will Be Featured in the Worldwide Leaders in HealthcareMarch 23rd, 2017
- Arboviral Infections Pose Serious Risks to Patients on RituximabJanuary 23rd, 2024